Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
Sobel
Burton E
BE
Department of Medicine, University of Vermont College of Medicine, University of Vermont, Colchester Research Facility, Colchester, Vermont 05446, USA. burton.sobel@uvm.edu
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000401:mortality; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000401:mortality; D003324:Coronary Artery Disease / Q000150:complications / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D007004:Hypoglycemic Agents